Transcription factors and potential therapeutic targets for pulmonary hypertension
Authors:
Open Access
- 17 March 2023
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 11, 1132060
Abstract
Pulmonary hypertension (PH) is a refractory and fatal disease characterized by excessive pulmonary arterial cell remodeling. Uncontrolled proliferation and hypertrophy of pulmonary arterial smooth muscle cells (PASMCs), dysfunction of pulmonary arterial endothelial cells (PAECs), and abnormal perivascular infiltration of immune cells result in pulmonary arterial remodeling, followed by increased pulmonary vascular resistance and pulmonary pressure. Although various drugs targeting nitric oxide, endothelin-1 and prostacyclin pathways have been used in clinical settings, the mortality of pulmonary hypertension remains high. Multiple molecular abnormalities have been implicated in pulmonary hypertension, changes in numerous transcription factors have been identified as key regulators in pulmonary hypertension, and a role for pulmonary vascular remodeling has been highlighted. This review consolidates evidence linking transcription factors and their molecular mechanisms, from pulmonary vascular intima PAECs, vascular media PASMCs, and pulmonary arterial adventitia fibroblasts to pulmonary inflammatory cells. These findings will improve the understanding of particularly interactions between transcription factor-mediated cellular signaling pathways and identify novel therapies for pulmonary hypertension.Keywords
Funding Information
- National Natural Science Foundation of China
- Guangdong Provincial Department of Science and Technology
- Fundamental Research Funds for the Central Universities
This publication has 197 references indexed in Scilit:
- TBX4 mutations (small patella syndrome) are associated with childhood-onset pulmonary arterial hypertensionJournal of Medical Genetics, 2013
- Hypoxia-Inducible Factors in Physiology and MedicineCell, 2012
- NFATc3 is required for chronic hypoxia-induced pulmonary hypertension in adult and neonatal miceAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2011
- Snail1 Mediates Hypoxia-Induced Melanoma ProgressionThe American Journal of Pathology, 2011
- Reduction of Reactive Oxygen Species Prevents Hypoxia-induced CREB Depletion in Pulmonary Artery Smooth Muscle CellsJournal of Cardiovascular Pharmacology, 2011
- Mammalian Krüppel-Like Factors in Health and DiseasesPhysiological Reviews, 2010
- Notch3 signaling promotes the development of pulmonary arterial hypertensionNature Medicine, 2009
- The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targetedProceedings of the National Academy of Sciences, 2007
- NFATc3 Mediates Chronic Hypoxia-induced Pulmonary Arterial Remodeling with α-Actin Up-regulationJournal of Biological Chemistry, 2007
- TGF‐β control of cell proliferationJournal of Cellular Biochemistry, 2005